FindTrial
Sign In

Screening Lipid Profile and Doppler Study in Children with Beta Thalassemia Major

Screening for Premature Atherosclerosis in Children with Beta Thalassemia Major - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055290
Enrollment
45
Registered
2023-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D561- Beta thalassemia

Interventions

Intervention1: nil: nil Intervention2: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Anusha Arbettu Kamath
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children between 6 months to 18 years of age admitted in Kasturba Hospital and diagnosed to have beta thalassemia major.

Exclusion criteria

Exclusion criteria: 1. Known case of congenital thyroid disorders, congenital heart disease, chronic renal disease, chronic hepatic disease 2. Family history of premature atherosclerosis (onset of symptoms 3. Family history of hypercholesterolemia 4. Children with BMI > 95th percentile 5. Children with hypertension according to age, sex and height

Design outcomes

Primary

MeasureTime frame
To study fasting lipid profile & carotid artery intima media thickness in children with beta thalassemia major.Timepoint: 2 years—

Secondary

MeasureTime frame
To correlate fasting lipid profile & carotid artery intima media thickness with serum ferritin level and chelation therapy in children with beta thalassemia major.Timepoint: 2 years—

Countries

India

Contacts

Public ContactAnusha Arbettu Kamath

Kasturba Medical College, Manipal

suneel.mundkur@manipal.edu9845150802

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026